Literature DB >> 18682025

Hypertension guidelines: thresholds, targets, and teratogenicity.

Una Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18682025      PMCID： PMC2486389          DOI： 10.3399/bjgp08X319800

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  5 in total

Review 1.  Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.

Authors:  Albert Quan
Journal:  Early Hum Dev       Date:  2006-01-19       Impact factor: 2.079

2.  Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.

Authors:  A Shotan; J Widerhorn; A Hurst; U Elkayam
Journal:  Am J Med       Date:  1994-05       Impact factor: 4.965

3.  Major congenital malformations after first-trimester exposure to ACE inhibitors.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon Dyer; Patricia S Gideon; Kathi Hall; Wayne A Ray
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

4.  Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

Authors:  B Williams; N R Poulter; M J Brown; M Davis; G T McInnes; J F Potter; P S Sever; S McG Thom
Journal:  J Hum Hypertens       Date:  2004-03       Impact factor: 3.012

5.  Use of ACE inhibitors and ARBs in hypertensive women of childbearing age.

Authors:  U Martin; M A Foreman; J C Travis; D Casson; J J Coleman
Journal:  J Clin Pharm Ther       Date:  2008-10       Impact factor: 2.512
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.